AI assistant
Sending…
ARTIVION, INC. — Director's Dealing 2019
Feb 19, 2019
31684_dirs_2019-02-19_55695490-6eda-4264-bf1b-9f85a503f6b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2018-12-31
Reporting Person: McDermid James M (SVP, CHRO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | Common Stock | M | 89 | $23.6725 | Acquired | 22603 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-01 | Stock Option (Right to Buy) | $23.6725 | A | 89 | Acquired | 2018-12-31 | Common Stock (89) | Direct |
| 2018-12-31 | Stock Option (Right to Buy) | $23.6725 | M | 89 | Disposed | 2018-12-31 | Common Stock (89) | Direct |
Footnotes
F1: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3.
F2: In a Form 4 filed on July 10, 2018, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such shares were reflected in the post-transaction amounts in column 5 of that Form 4. Beneficially owned shares are hereby updated in column 5 on this Form 5 to remove such previously-added shares.
More from ARTIVION, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3